Simon Medtech Solutions
ANPP Launches an Upgraded Digital Regulatory Platform for Pharmaceutical and Medical Device Establishments
On 25 September 2025, the National Agency for Pharmaceutical Products (ANPP) in Algeria published an official note (41/MIP/ANPP/DG/NOTE/2025) addressed to licensed pharmaceutical establishments, including manufacturers, operators, and importers of pharmaceutical products and medical devices for human use.
This initiative is part of the National Program for the Digitalization of Regulatory Activities led by the ANPP, aimed at modernizing regulatory processes and strengthening traceability, efficiency, and transparency.
Mandatory Registration on the New ANPP Digital Platform
According to the published note, all Technical Directors of authorized pharmaceutical establishments are required to register on the new version of the ANPP digital platform by creating a new user account via the official link provided by the authority.
The upgraded platform includes several optimizations designed to deliver a more efficient and user-friendly experience, supporting the digital management of regulatory interactions between industry stakeholders and the ANPP.
Go-live date: Sunday, 28 September 2025
Access link: https://etasjil.anpp.dz
It is important to note that this registration requires the creation of a new account, even for establishments that were previously registered on the former version of the platform.
Regulatory and Operational Impact for Industry Stakeholders
This regulatory update has direct implications for companies planning to operate or already active in the Algerian pharmaceutical and medical device market, including:
Continuity of regulatory submissions and interactions with the ANPP
Compliance with updated digital regulatory processes
Internal organization and designation of responsible persons
Alignment of ongoing and future regulatory projects with the new platform requirements
Failure to comply with this requirement may result in administrative delays, disruptions in regulatory activities, or difficulties in market access.
How Simon MedTech Solutions Can Support You
At Simon MedTech Solutions, we support pharmaceutical and medical device manufacturers, operators, and importers in analyzing the regulatory impact of new regulatory publications across Africa and the Middle East.
In relation to this ANPP update, our services include:
Regulatory impact assessment on current and future projects in Algeria
Gap analysis against the new digital registration requirements
Operational support for platform registration and documentation readiness
Strategic regulatory guidance to ensure uninterrupted compliance
Our objective is to help industry stakeholders anticipate regulatory changes, minimize risks, and maintain a smooth and compliant market access strategy in Algeria.
Contact us to assess how this regulatory update may affect your activities and to receive tailored regulatory support.
